Article Text

PDF
Acute coronary syndrome registry from four large centres in United Arab Emirates (UAE-ACS Registry)
  1. Afzalhussein M Yusufali1,
  2. Wael AlMahmeed2,
  3. Sadeq Tabatabai1,
  4. Kabad Rao3,
  5. Azan Binbrek3
  1. 1Dubai Heart Centre, DHA, Dubai, UAE
  2. 2Sheikh Khalifa Medical City, Abu Dhabi, UAE
  3. 3Rashid Hospital, DHA, Dubai, UAE
  1. Correspondence to Dr Afzalhussein M Yusufali, Dubai Heart Centre, Box 7272, Dubai, UAE; ahyusufali{at}dha.gov.ae

Abstract

Objective To identify the characteristics, treatments and hospital outcomes of patients diagnosed as having acute coronary syndrome (ACS) in the United Arab Emirates (UAE).

Design A 3-year prospective registry.

Setting Four tertiary care hospitals in three major cities of UAE from December 2003 to December 2006.

Patients 1842 eligible consecutive patients with suspected ACS.

Interventions None.

Main outcome measures Characteristics, treatments and in-hospital outcomes were recorded.

Results The mean age was 50.8±10.0 years, and 93.1% were male. More than half (51%) had ST elevation myocardial infarction (STEMI). The smoking rate was 46.4%, and diabetes was present in 38.9%. Only a minority (17.3%) used the ambulance services. For patients with STEMI, the median symptom to hospital time was 127 (IQR 60–256) min, and the median diagnostic ECG to thrombolysis time was 28 (IQR 16–50) min. Reperfusion in STEMI was in 81.4% (64.8% thrombolysis and 16.6% primary percutaneous coronary intervention). During hospitalisation, only a minority of the patients did not receive antiplatelets, anticoagulants, beta-blockers, ACE inhibitors and statin therapy. In-hospital complications were not common in our registry cohort. In-hospital mortality was 1.68%.

Conclusions ACS patients in UAE are young but have higher risk factors such as smoking and diabetes. Almost half present as STEMI. Only a minority use ambulance services.

Statistics from Altmetric.com

Footnotes

  • Funding MSD partly funded this project.

  • Competing interests None.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.